694439-03-7 Usage
Uses
Used in Organic Synthesis:
(4aR,7aS)-tert-butyl tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrole-6(3H)-carboxylate is used as a building block in organic synthesis for the creation of various chemical compounds. Its unique structure and functional groups make it a valuable component in the synthesis of complex organic molecules.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (4aR,7aS)-tert-butyl tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrole-6(3H)-carboxylate is used as a potential drug candidate. Its pharmacological activities and unique structure make it a promising candidate for the development of new therapeutic agents.
Used in Pharmaceutical Industry:
(4aR,7aS)-tert-butyl tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrole-6(3H)-carboxylate is used as a key intermediate in the synthesis of pharmaceutical compounds. Its potential as a building block for biologically active compounds makes it a valuable asset in the development of new drugs and therapeutic agents.
Used in Drug Discovery:
(4aR,7aS)-tert-butyl tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrole-6(3H)-carboxylate is used as a starting material in drug discovery for the identification and development of novel therapeutic agents. Its unique structure and potential pharmacological activities make it a promising candidate for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 694439-03-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,4,4,3 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 694439-03:
(8*6)+(7*9)+(6*4)+(5*4)+(4*3)+(3*9)+(2*0)+(1*3)=197
197 % 10 = 7
So 694439-03-7 is a valid CAS Registry Number.
694439-03-7Relevant academic research and scientific papers
Vascular endothelial growth factor receptor inhibitor and preparation method and application thereof
-
Paragraph 0148-0153, (2020/12/14)
The invention provides a vascular endothelial growth factor receptor inhibitor and a preparation method and application thereof, and relates to a quinoline or quinazoline derivative with a structure as shown in a formula (I), a pharmaceutical composition containing a compound as shown in the formula (I) and application of the compound in preparation of drugs for preventing or treating angiogenesis-related diseases, in particular to prevention or treatment of tumors related to protein tyrosine kinase. Each substituent in the formula (I) is the same as the definition in the specification.
Synthesis of Functionalized 1,4-Dioxanes with an Additional (Hetero)Aliphatic Ring
Bondarenko, Andriy V.,Tolmachev, Andrey A.,Vashchenko, Bohdan V.,Grygorenko, Oleksandr O.
, p. 3696 - 3707 (2018/09/14)
An approach to the preparation of 2-mono-, 2,2- and 2,3-disubstituted 1,4-dioxane derivatives is described. The reaction sequence commences from readily available epoxides, in most cases prepared via the Corey-Chaikovsky reaction of the corresponding aldehydes and ketones. The key step of the method is epoxide ring opening with ethylene glycol monosodium salt, followed by further cyclization of the diols obtained. The utility of the approach was demonstrated by multigram preparation of novel functionalized 1,4-dioxanes bearing additional cycloalkane, piperidine or pyrrolidine rings, mostly spirocyclic compounds, which are advanced building blocks for medicinal chemistry.
